Q1 2023 Delcath Systems Inc Earnings Call Transcript
Good day and welcome to the Delcath Systems reports first quarter fiscal 2023 financial results call. (Operator Instructions) Please note that this event is being recorded.
I would now like to turn the conference over to David Hoffman, General Counsel. Please go ahead.
Thank you. And once again, welcome to Delcath Systems 2023 first-quarter earnings call. With me on the call are Gerard Michel, Chief Executive Officer; Dr. Johnny John, Senior Vice President of Medical Affairs and Clinical Development; Kevin Muir, General Manager of US Interventional Oncology; John Purpura, Chief Operating Officer; and Anthony Dias, Vice President of Finance.
I'd like to begin the call by reading a Safe Harbor statement. This statement is made pursuant to the Safe Harbor for forward-looking statements described in the Private Securities Litigation Reform Act of 1995. All statements made on this call with the exception of historical facts may be considered
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |